Search for a report

NORTH AMERICA STEM CELL MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA STEM CELL MARKET FORECAST 2021-2028

NORTH AMERICA STEM CELL MARKET FORECAST 2021-2028

The North America stem cell market is anticipated to grow with a CAGR of 7.69%, over the forecast period of 2021 to 2028. The region’s key market growth drivers include growing investments in research and development activities and the surging number of chronic diseases. The North America stem cell market growth is evaluated across the United States and Canada.

NORTH AMERICA STEM CELL MARKET FORECAST 2021-2028

North America Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries and Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) by Product (Adult Stem Cell (Hematopoietic Stem Cell, Neural Stem, Umbilical Cord Stem Cell, Mesenchymal Stem Cell, Dental Stem Cell), Human Embryonic Stem Cell, Pluripotent, Mouse/rat Neural) by Technology (Acquisition (Stem Cell Bone Marrow Market, Stem Cell Apheresis, Stem Cell Umbilical Cord), Cryopreservation, Expansion and Sub-culture, Production (Stem Cell Culture, Therapeutic Cloning, Ivf)) by Application (Regenerative Medicine, Drug Discovery and Development) by Treatment Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy) and by Geography.

Request free sample

The North America stem cell market is anticipated to grow with a CAGR of 7.69%, over the forecast period of 2021 to 2028. The region’s key market growth drivers include growing investments in research and development activities and the surging number of chronic diseases.
north-america-stem-cell-market-trends

To learn more about this report, request a free sample copy

The North America stem cell market growth is evaluated across the United States and Canada. The growing expenditure on research and development, in order to develop new stem cell therapies for rare and chronic conditions, essentially drives the market in the United States. Additionally, the country harbors an improved healthcare infrastructure, when compared to other emerged countries. The United States also has a large number of products within the pipeline for stem cell therapies.

As per the American Cancer Society’s estimations, the United States observed nearly 609,640 cancer fatalities and 1,735,350 new cancer cases in 2018. Besides, it is also projected that the country will diagnose at least 1.8 million new cancer cases in 2020, with more than 606,500 deaths related to cancer. As a result, the increasing number of cancer cases provides lucrative opportunities for key market players while concentrating on research and development activities to introduce new stem cell therapies. Hence, these factors are expected to drive the country’s stem cell market growth over the forecast period.

Becton, Dickinson and Company (BD), headquartered in the United States, is an international medical technology enterprise, primarily involved in developing, manufacturing, and distributing laboratory equipment, medical devices, and diagnostic products. Its major products include infusion pumps and disposables, intravenous catheters, automated medication dispensing systems, respiratory ventilation and diagnostics equipment, etc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      •    KEY DRIVERS
        • SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
        • GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
        • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
        • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
        • TECHNOLOGICAL ADVANCEMENTS
      •    KEY RESTRAINTS
        • STRINGENT GOVERNMENT REGULATIONS
        • HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
        • ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
        • LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES
    1. KEY ANALYTICS
      •    PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON STEM CELL MARKET
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
      • HISTORY OF STEM CELL
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    2. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    3. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    4. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY
    3. GEOGRAPHICAL ANALYSIS
      •    NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      •    KEY STRATEGIC DEVELOPMENTS
        • MERGER & ACQUISITIONS
        • PRODUCT LAUNCH & DEVELOPMENTS
        • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
        • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
      •    COMPANY PROFILE
        • ALLCELLS LLC
        • BECTON, DICKINSON AND COMPANY (BD)
        • CORNING INC
        • CYTORI THERAPEUTICS
        • GE HEALTHCARE
        • INTERNATIONAL STEM CELL CORP
        • MERCK KGAA (SIGMA ALDRICH)
        • MILTENYI BIOTEC
        • PLURISTEM THERAPEUTICS INC
        • QIAGEN NV
        • SMITH & NEPHEW PLC
        • STEMCELL TECHNOLOGIES
        • STRYKER CORPORATION
        • TAKARA HOLDINGS INC
        • THERMO FISHER SCIENTIFIC INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – STEM CELL

    TABLE 2: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: NORTH AMERICA ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: NORTH AMERICA PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: NORTH AMERICA STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: NORTH AMERICA STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET

    FIGURES LIST

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020

    FIGURE 6: NORTH AMERICA STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA STEM CELL MARKET, BY PRODUCT, IN 2020

    FIGURE 14: NORTH AMERICA STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA STEM CELL MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 24: NORTH AMERICA STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

    FIGURE 25: NORTH AMERICA STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

    FIGURE 28: NORTH AMERICA STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

    FIGURE 30: NORTH AMERICA STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

    FIGURE 31: NORTH AMERICA STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

    FIGURE 32: NORTH AMERICA STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

    FIGURE 33: NORTH AMERICA STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

    FIGURE 34: NORTH AMERICA STEM CELL MARKET, BY APPLICATION, IN 2020

    FIGURE 35: NORTH AMERICA STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

    FIGURE 36: NORTH AMERICA STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

    FIGURE 37: NORTH AMERICA STEM CELL MARKET, BY TREATMENT TYPE, IN 2020

    FIGURE 38: NORTH AMERICA STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 39: NORTH AMERICA STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 40: NORTH AMERICA STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 41: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 42: UNITED STATES STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 43: CANADA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    2. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    3. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now